The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 5,816 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 403 | 100,759 | SH | SOLE | 100,759 | 0 | 0 | ||
| ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 9,294 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| ARK ETF TR | GENOMIC REV ETF | 00214Q302 | 1,531 | 25,000 | SH | Call | SOLE | 25,000 | 0 | 0 | |
| ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 3,972 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| ARYA SCIENCES ACQUISITN CORP | CLASS A ORD SHS | G31658100 | 6,807 | 702,500 | SH | SOLE | 702,500 | 0 | 0 | ||
| BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 4,025 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | 8,241 | 494,046 | SH | SOLE | 494,046 | 0 | 0 | ||
| BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | 10806XAB8 | 5,529 | 7,500,000 | PRN | SOLE | 7,500,000 | 0 | 0 | ||
| CASSAVA SCIENCES INC | COM | 14817C107 | 15,295 | 350,000 | SH | Put | SOLE | 350,000 | 0 | 0 | |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 3,864 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 4,720 | 419,144 | SH | SOLE | 419,144 | 0 | 0 | ||
| CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 7,295 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| CHINOOK THERAPEUTICS INC | COM | 16961L106 | 9,055 | 555,155 | SH | SOLE | 555,155 | 0 | 0 | ||
| CUREVAC N V | COM | N2451R105 | 1,716 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
| CURIS INC | COM NEW | 231269200 | 4,998 | 1,050,000 | SH | Call | SOLE | 1,050,000 | 0 | 0 | |
| CURIS INC | COM NEW | 231269200 | 3,094 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
| CYCLACEL PHARMACEUTICALS INC | COM | 23254L603 | 1,548 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 3,793 | 1,122,244 | SH | SOLE | 1,122,244 | 0 | 0 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | 6,634 | 145,552 | SH | SOLE | 145,552 | 0 | 0 | ||
| ENVIRONMENTAL IMPACT ACQU CO | COM CL A | 29408N106 | 2,976 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 5,238 | 77,500 | SH | SOLE | 77,500 | 0 | 0 | ||
| HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 3,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| HYPERFINE INC | COM CL A | 44916K106 | 552 | 76,162 | SH | SOLE | 76,162 | 0 | 0 | ||
| IMMATICS N.V | *W EXP 07/01/2020 | N44445117 | 834 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
| INARI MED INC | COM | 45332Y109 | 11,409 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| INOVIO PHARMACEUTICALS INC | COM NEW | 45773H201 | 998 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
| INTELLIA THERAPEUTICS INC | COM | 45826J105 | 1,182 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 382 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 7,840 | 560,000 | SH | SOLE | 560,000 | 0 | 0 | ||
| LIANBIO SPONSORED | ADS | 53000N108 | 446 | 72,406 | SH | SOLE | 72,406 | 0 | 0 | ||
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 5,508 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
| MEDICUS SCIENCES ACQUISITION | CL A SHS | G5960S108 | 2,916 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/2026 | G5960S124 | 24 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 2,934 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| MODERNA INC | COM | 60770K107 | 7,619 | 30,000 | SH | Put | SOLE | 30,000 | 0 | 0 | |
| MORPHIC HLDG INC | COM | 61775R105 | 18,919 | 399,302 | SH | SOLE | 399,302 | 0 | 0 | ||
| NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 5,438 | 1,049,721 | SH | SOLE | 1,049,721 | 0 | 0 | ||
| NOVAVAX INC | COM NEW | 670002401 | 7,154 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | |
| PROCEPT BIOROBOTICS CORP | COM | 74276L105 | 2,501 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 8,246 | 241,119 | SH | SOLE | 241,119 | 0 | 0 | ||
| RAFAEL HLDGS INC | COM CL B | 75062E106 | 516 | 101,200 | SH | Put | SOLE | 101,200 | 0 | 0 | |
| RENOVACOR INC | COM | 75989E106 | 963 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| RENOVACOR INC | *W EXP 99/99/999 | 75989E114 | 43 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| REPARE THERAPEUTICS INC | COM | 760273102 | 5,732 | 271,778 | SH | SOLE | 271,778 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 3,602 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
| SCIENCE 37 HOLDINGS INC | COM | 808644108 | 1,871 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| SEER INC | COM CL A | 81578P106 | 1,141 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
| SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 18,504 | 298,545 | SH | SOLE | 298,545 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 3,831 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 | 761299AB2 | 7,731 | 7,000,000 | PRN | SOLE | 7,000,000 | 0 | 0 | ||
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | 1,552 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| VINCERX PHARMA INC | COM NEW | 92731L106 | 11,569 | 1,135,365 | SH | SOLE | 1,135,365 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 4,702 | 150,500 | SH | SOLE | 150,500 | 0 | 0 | ||
| ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 9,877 | 117,500 | SH | SOLE | 117,500 | 0 | 0 | ||